118
Views
4
CrossRef citations to date
0
Altmetric
Meta-analysis

Favipiravir-based treatment for outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials

, , , , &
Pages 759-766 | Received 15 Jan 2022, Accepted 03 May 2022, Published online: 30 May 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pasquale Pagliano, Carmine Sellitto, Tiziana Ascione, Giuliana Scarpati, Veronica Folliero, Ornella Piazza, Gianluigi Franci, Amelia Filippelli & Valeria Conti. (2022) The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19). Expert Opinion on Drug Discovery 17:12, pages 1299-1311.
Read now
Tzu-Chieh Weng, Teng-Song Weng, Chih-Cheng Lai, Chien-Ming Chao & Jui-Hsiang Wang. (2022) Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Expert Review of Anti-infective Therapy 20:12, pages 1615-1622.
Read now

Articles from other publishers (2)

Kritika Chetty, Iek Cheng, Marios Kaliakatsos, Luis Ignacio Gonzalez-Granado, Dimitra Klapsa, Javier Martin, Alasdair Bamford, Judith Breuer & Claire Booth. (2022) Case report: Novel treatment regimen for enterovirus encephalitis in SCID. Frontiers in Immunology 13.
Crossref
Chih-Cheng Lai, Ya-Hui Wang, Kuang-Hung Chen, Chao-Hsien Chen & Cheng-Yi Wang. (2022) The Clinical Efficacy and Safety of Anti-Viral Agents for Non-Hospitalized Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Viruses 14:8, pages 1706.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.